351 related articles for article (PubMed ID: 9343195)
1. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.
Quinn DG; Zajac AJ; Hioe CE; Frelinger JA
J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
3. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
[TBL] [Abstract][Full Text] [Related]
4. Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains.
Ahmed R; Byrne JA; Oldstone MB
J Virol; 1984 Jul; 51(1):34-41. PubMed ID: 6610062
[TBL] [Abstract][Full Text] [Related]
5. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
6. Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells.
Quinn DG; Zajac AJ; Frelinger JA; Muller D
Int Immunol; 1993 Oct; 5(10):1193-8. PubMed ID: 7903551
[TBL] [Abstract][Full Text] [Related]
7. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.
Muller D; Koller BH; Whitton JL; LaPan KE; Brigman KK; Frelinger JA
Science; 1992 Mar; 255(5051):1576-8. PubMed ID: 1347959
[TBL] [Abstract][Full Text] [Related]
8. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
Moskophidis D; Zinkernagel RM
J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
[TBL] [Abstract][Full Text] [Related]
9. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
Klavinskis LS; Whitton JL; Oldstone MB
J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571
[TBL] [Abstract][Full Text] [Related]
10. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
[TBL] [Abstract][Full Text] [Related]
11. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
12. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
13. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
Cook JR; Solheim JC; Connolly JM; Hansen TH
J Immunol; 1995 Jan; 154(1):47-57. PubMed ID: 7995959
[TBL] [Abstract][Full Text] [Related]
14. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
[TBL] [Abstract][Full Text] [Related]
15. In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.
Puglielli MT; Zajac AJ; van der Most RG; Dzuris JL; Sette A; Altman JD; Ahmed R
J Virol; 2001 Jun; 75(11):5099-107. PubMed ID: 11333891
[TBL] [Abstract][Full Text] [Related]
16. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
Hudrisier D; Oldstone MB; Gairin JE
Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
[TBL] [Abstract][Full Text] [Related]
17. An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus.
Chen L; Jay DC; Fairbanks JD; He X; Jensen PE
J Immunol; 2011 Dec; 187(12):6463-72. PubMed ID: 22084437
[TBL] [Abstract][Full Text] [Related]
18. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
Byrne JA; Oldstone MB
J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
[TBL] [Abstract][Full Text] [Related]
19. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.
Rall GF; Mucke L; Oldstone MB
J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191
[TBL] [Abstract][Full Text] [Related]
20. Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.
Hioe CE; McKinney DM; Frelinger JA; McMillan M
Immunogenetics; 1994; 40(3):222-9. PubMed ID: 7518804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
